Literature DB >> 19211783

Agonizing over agonism: should asthmatics turn their beta-receptors on or off?

Raymond B Penn1.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19211783      PMCID： PMC2650113          DOI： 10.1073/pnas.0812935106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  16 in total

Review 1.  Beta-adrenergic receptors in the failing heart: the good, the bad, and the unknown.

Authors:  S B Liggett
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

Review 2.  Adverse effects of beta-agonists.

Authors:  Malcolm R Sears
Journal:  J Allergy Clin Immunol       Date:  2002-12       Impact factor: 10.793

Review 3.  Embracing emerging paradigms of G protein-coupled receptor agonism and signaling to address airway smooth muscle pathobiology in asthma.

Authors:  Raymond B Penn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-02-16       Impact factor: 3.000

4.  The safety and effects of the beta-blocker, nadolol, in mild asthma: an open-label pilot study.

Authors:  Nicola A Hanania; Supria Singh; Rami El-Wali; Michael Flashner; Amie E Franklin; William J Garner; Burton F Dickey; Sergio Parra; Stephen Ruoss; Felix Shardonofsky; Brian J O'Connor; Clive Page; Richard A Bond
Journal:  Pulm Pharmacol Ther       Date:  2007-07-17       Impact factor: 3.410

5.  Bronchial response to beta-adrenergic blockade.

Authors:  G Zaid; G N Beall
Journal:  N Engl J Med       Date:  1966-09-15       Impact factor: 91.245

Review 6.  Cardioselective beta-blockers for reversible airway disease.

Authors:  S Salpeter; T Ormiston; E Salpeter
Journal:  Cochrane Database Syst Rev       Date:  2002

7.  Beta2-adrenoceptor signaling is required for the development of an asthma phenotype in a murine model.

Authors:  Long P Nguyen; Rui Lin; Sergio Parra; Ozozoma Omoluabi; Nicola A Hanania; Michael J Tuvim; Brian J Knoll; Burton F Dickey; Richard A Bond
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-26       Impact factor: 11.205

8.  Chronic exposure to beta-blockers attenuates inflammation and mucin content in a murine asthma model.

Authors:  Long P Nguyen; Ozozoma Omoluabi; Sergio Parra; Joanna M Frieske; Cecilia Clement; Zoulikha Ammar-Aouchiche; Samuel B Ho; Camille Ehre; Mehmet Kesimer; Brian J Knoll; Michael J Tuvim; Burton F Dickey; Richard A Bond
Journal:  Am J Respir Cell Mol Biol       Date:  2007-12-20       Impact factor: 6.914

9.  Effects of acute and chronic administration of beta-adrenoceptor ligands on airway function in a murine model of asthma.

Authors:  Zsuzsanna Callaerts-Vegh; Kenda L J Evans; Noornabi Dudekula; Donald Cuba; Brian J Knoll; Patrick F K Callaerts; Heather Giles; Felix R Shardonofsky; Richard A Bond
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-06       Impact factor: 11.205

10.  Changes in beta 2-adrenoceptor and other signaling proteins produced by chronic administration of 'beta-blockers' in a murine asthma model.

Authors:  Rui Lin; Hui Peng; Long P Nguyen; Noor B Dudekula; Felix Shardonofsky; Brian J Knoll; Sergio Parra; Richard A Bond
Journal:  Pulm Pharmacol Ther       Date:  2007-07-04       Impact factor: 3.410
View more
  9 in total

1.  Beta-agonist-associated reduction in RGS5 expression promotes airway smooth muscle hyper-responsiveness.

Authors:  Zhao Yang; Philip R Cooper; Gautam Damera; Indranil Mukhopadhyay; Hyeseon Cho; John H Kehrl; Reynold A Panettieri; Kirk M Druey
Journal:  J Biol Chem       Date:  2011-01-29       Impact factor: 5.157

2.  Inhibition of protein phosphatase 2A activity by PI3Kγ regulates β-adrenergic receptor function.

Authors:  Neelakantan T Vasudevan; Maradumane L Mohan; Manveen K Gupta; Afshan K Hussain; Sathyamangla V Naga Prasad
Journal:  Mol Cell       Date:  2011-03-18       Impact factor: 17.970

3.  Dynamics of the beta2-adrenergic G-protein coupled receptor revealed by hydrogen-deuterium exchange.

Authors:  Xi Zhang; Ellen Y T Chien; Michael J Chalmers; Bruce D Pascal; Jovylyn Gatchalian; Raymond C Stevens; Patrick R Griffin
Journal:  Anal Chem       Date:  2010-02-01       Impact factor: 6.986

Review 4.  Clinical implications of the intrinsic efficacy of beta-adrenoceptor drugs in asthma: full, partial and inverse agonism.

Authors:  Nicola A Hanania; Burton F Dickey; Richard A Bond
Journal:  Curr Opin Pulm Med       Date:  2010-01       Impact factor: 3.155

Review 5.  Novel cAMP signalling paradigms: therapeutic implications for airway disease.

Authors:  Charlotte K Billington; Ian P Hall
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

6.  Label-free integrative pharmacology on-target of drugs at the β(2)-adrenergic receptor.

Authors:  Ann M Ferrie; Haiyan Sun; Ye Fang
Journal:  Sci Rep       Date:  2011-07-07       Impact factor: 4.379

7.  Defective Resensitization in Human Airway Smooth Muscle Cells Evokes β-Adrenergic Receptor Dysfunction in Severe Asthma.

Authors:  Manveen K Gupta; Kewal Asosingh; Mark Aronica; Suzy Comhair; Gaoyuan Cao; Serpil Erzurum; Reynold A Panettieri; Sathyamangla V Naga Prasad
Journal:  PLoS One       Date:  2015-05-29       Impact factor: 3.240

8.  A Systematic Review of Inverse Agonism at Adrenoceptor Subtypes.

Authors:  Martin C Michel; Martina B Michel-Reher; Peter Hein
Journal:  Cells       Date:  2020-08-19       Impact factor: 6.600

9.  Multiple facets of cAMP signalling and physiological impact: cAMP compartmentalization in the lung.

Authors:  Anouk Oldenburger; Harm Maarsingh; Martina Schmidt
Journal:  Pharmaceuticals (Basel)       Date:  2012-11-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.